Pennsylvania legislation · 2025-2026 Regular Session
Pennsylvania HB2734: An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.
Status: In committee, August 18, 2026
What the bill says
An act relating to insurance; amending, revising, and consolidating the law providing for the incorporation of insurance companies, and the regulation, supervision, and protection of home and foreign insurance companies, Lloyds associations, reciprocal and inter-insurance exchanges, and fire insurance rating bureaus, and the regulation and supervision of insurance carried by such companies, associations, and exchanges, including insurance carried by the State Workmen's Insurance Fund; providing penalties…
From the introduced text, August 18, 2026:
An act relating to insurance; amending, revising, and consolidating the law providing for the incorporation of insurance companies, and the regulation, supervision, and protection of home and foreign insurance companies, Lloyds associations, reciprocal and inter-insurance exchanges, and fire insurance rating bureaus, and the regulation and supervision of insurance carried by such companies, associations, and exchanges, including insurance carried by the State Workmen's Insurance Fund; providing penalties; and repealing existing laws," in casualty insurance, providing for coverage for treatments to slow the progression of Alzheimer's disease and related dementias. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. The act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, is amended by adding a section to read: Section 635.11. Coverage for Treatments to Slow the Progression of Alzheimer's Disease and Related Dementias.--(a) No later than January 1, 2028, an insurer that offers, issues or renews a health insurance policy in this Commonwealth, to the extent not preempted by Federal law, shall provide coverage for all medically necessary diagnostic testing and treatment or medication approved by the United States Food and Drug Administration prescribed by a health care practitioner to slow the progression of Alzheimer's disease or another related dementia. (b) Coverage under this section shall not include step therapy. (c) As …